{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:51:21Z","timestamp":1762980681737},"reference-count":51,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,4,25]]},"DOI":"10.1253\/circj.cj-19-0096","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:04:50Z","timestamp":1554415490000},"page":"952-962","source":"Crossref","is-referenced-by-count":6,"title":["Current Key Issues in Transcatheter Aortic Valve Replacement Undergoing a Paradigm Shift"],"prefix":"10.1253","volume":"83","author":[{"given":"In-Chang","family":"Hwang","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital"},{"name":"Cardiovascular Center, Department of Internal Medicine, Seoul National University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Hayashida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Department of Internal Medicine, Seoul National University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Fenn J, Raskino M. Mastering the hype cycle: How to choose the right innovation at the right time. Brighton, MA: Harvard Business Press, 2008; 25\u201346."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2017; 70: 252\u2013289.","DOI":"10.1016\/j.jacc.2017.03.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. <i>Eur Heart J<\/i> 2017; 38: 2739\u20132791.","DOI":"10.1093\/eurheartj\/ehx391"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): A randomised controlled trial. <i>Lancet<\/i> 2015; 385: 2485\u20132491.","DOI":"10.1016\/S0140-6736(15)60290-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): A randomised controlled trial. <i>Lancet<\/i> 2015; 385: 2477\u20132484.","DOI":"10.1016\/S0140-6736(15)60308-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. <i>N Engl J Med<\/i> 2016; 374: 1609\u20131620.","DOI":"10.1056\/NEJMoa1514616"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, et al. 2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. <i>J Am Coll Cardiol<\/i> 2015; 66: 113\u2013121.","DOI":"10.1016\/j.jacc.2015.05.017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. <i>N Engl J Med<\/i> 2017; 376: 1321\u20131331.","DOI":"10.1056\/NEJMoa1700456"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sondergaard L, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial. <i>Circ Cardiovasc Interv<\/i> 2016; 9: e003665.","DOI":"10.1161\/CIRCINTERVENTIONS.115.003665"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis. <i>J Am Coll Cardiol<\/i> 2018; 72: 2095\u20132105.","DOI":"10.1016\/j.jacc.2018.08.1033"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sondergaard L, Ihlemann N, Capodanno D, Jorgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. <i>J Am Coll Cardiol<\/i> 2019; 73: 546\u2013553.","DOI":"10.1016\/j.jacc.2018.10.083"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O\u2019Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. <i>N Engl J Med<\/i>, doi:10.1056\/NEJMoa1816885.","DOI":"10.1056\/NEJMoa1816885"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. <i>N Engl J Med<\/i>, doi:10.1056\/NEJMoa1814052.","DOI":"10.1056\/NEJMoa1814052"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Afilalo J, Lauck S, Kim DH, Lefevre T, Piazza N, Lachapelle K, et al. Frailty in older adults undergoing aortic valve replacement: The FRAILTY-AVR Study. <i>J Am Coll Cardiol<\/i> 2017; 70: 689\u2013700.","DOI":"10.1016\/j.jacc.2017.06.024"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shimura T, Yamamoto M, Kano S, Kagase A, Kodama A, Koyama Y, et al. Impact of frailty markers on outcomes after transcatheter aortic valve replacement: Insights from a Japanese multicenter registry. <i>Ann Cardiothorac Surg<\/i> 2017; 6: 532\u2013537.","DOI":"10.21037\/acs.2017.09.06"},{"key":"16","unstructured":"16. Shimura T, Yamamoto M, Kano S, Hosoba S, Sago M, Kagase A, et al. Patients refusing transcatheter aortic valve replacement even once have poorer clinical outcomes. <i>J Am Heart Assoc<\/i> 2018; 7: e009195."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Khalique OK, Hahn RT, Gada H, Nazif TM, Vahl TP, George I, et al. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. <i>JACC Cardiovasc Interv<\/i> 2014; 7: 885\u2013894.","DOI":"10.1016\/j.jcin.2014.03.007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Park JB, Hwang IC, Lee W, Han JK, Kim CH, Lee SP, et al. Quantified degree of eccentricity of aortic valve calcification predicts risk of paravalvular regurgitation and response to balloon post-dilation after self-expandable transcatheter aortic valve replacement. <i>Int J Cardiol<\/i> 2018; 259: 60\u201368.","DOI":"10.1016\/j.ijcard.2017.12.052"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hayashida K, Bouvier E, Lefevre T, Hovasse T, Morice MC, Chevalier B, et al. Potential mechanism of annulus rupture during transcatheter aortic valve implantation. <i>Catheter Cardiovasc Interv<\/i> 2013; 82: E742\u2013E746.","DOI":"10.1002\/ccd.24524"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Schafers HJ, Schmied W, Marom G, Aicher D. Cusp height in aortic valves. <i>J Thorac Cardiovasc Surg<\/i> 2013; 146: 269\u2013274.","DOI":"10.1016\/j.jtcvs.2012.06.053"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hayashida K, Bouvier E, Lefevre T, Chevalier B, Hovasse T, Romano M, et al. Transcatheter aortic valve implantation for patients with severe bicuspid aortic valve stenosis. <i>Circ Cardiovasc Interv<\/i> 2013; 6: 284\u2013291.","DOI":"10.1161\/CIRCINTERVENTIONS.112.000084"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yoon SH, Bleiziffer S, De Backer O, Delgado V, Arai T, Ziegelmueller J, et al. Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. <i>J Am Coll Cardiol<\/i> 2017; 69: 2579\u20132589.","DOI":"10.1016\/j.jacc.2017.03.017"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Herrmann HC, Daneshvar SA, Fonarow GC, Stebbins A, Vemulapalli S, Desai ND, et al. Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement: From the STS\/ACC TVT Registry. <i>J Am Coll Cardiol<\/i> 2018; 72: 2701\u20132711.","DOI":"10.1016\/j.jacc.2018.09.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pibarot P, Weissman NJ, Stewart WJ, Hahn RT, Lindman BR, McAndrew T, et al. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: A PARTNER trial cohort-a analysis. <i>J Am Coll Cardiol<\/i> 2014; 64: 1323\u20131334.","DOI":"10.1016\/j.jacc.2014.06.1195"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kamperidis V, van Rosendael PJ, de Weger A, Katsanos S, Regeer M, van der Kley F, et al. Surgical sutureless and transcatheter aortic valves: Hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis. <i>JACC Cardiovasc Interv<\/i> 2015; 8: 670\u2013677.","DOI":"10.1016\/j.jcin.2014.10.029"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kalavrouziotis D, Rodes-Cabau J, Bagur R, Doyle D, De Larochelliere R, Pibarot P, et al. Transcatheter aortic valve implantation in patients with severe aortic stenosis and small aortic annulus. <i>J Am Coll Cardiol<\/i> 2011; 58: 1016\u20131024.","DOI":"10.1016\/j.jacc.2011.05.026"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Miyasaka M, Tada N, Taguri M, Kato S, Enta Y, Otomo T, et al. Incidence, predictors, and clinical impact of prosthesis-patient mismatch following transcatheter aortic valve replacement in Asian patients: The OCEAN-TAVI registry. <i>JACC Cardiovasc Interv<\/i> 2018; 11: 771\u2013780.","DOI":"10.1016\/j.jcin.2018.01.273"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yashima F, Yamamoto M, Tanaka M, Yanagisawa R, Arai T, Shimizu H, et al. Transcatheter aortic valve implantation in patients with an extremely small native aortic annulus: The OCEAN-TAVI registry. <i>Int J Cardiol<\/i> 2017; 240: 126\u2013131.","DOI":"10.1016\/j.ijcard.2017.01.076"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Franzone A, Piccolo R, Siontis GC, Lanz J, Stortecky S, Praz F, et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: A systematic review. <i>JACC Cardiovasc Interv<\/i> 2016; 9: 2308\u20132317.","DOI":"10.1016\/j.jcin.2016.08.049"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yoon SH, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. <i>J Am Coll Cardiol<\/i> 2017; 70: 2752\u20132763.","DOI":"10.1016\/j.jacc.2017.10.006"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. van Gils L, Clavel MA, Vollema EM, Hahn RT, Spitzer E, Delgado V, et al. Prognostic implications of moderate aortic stenosis in patients with left ventricular systolic dysfunction. <i>J Am Coll Cardiol<\/i> 2017; 69: 2383\u20132392.","DOI":"10.1016\/j.jacc.2017.03.023"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Clavel MA, Berthelot-Richer M, Le Ven F, Capoulade R, Dahou A, Dumesnil JG, et al. Impact of classic and paradoxical low flow on survival after aortic valve replacement for severe aortic stenosis. <i>J Am Coll Cardiol<\/i> 2015; 65: 645\u2013653.","DOI":"10.1016\/j.jacc.2014.11.047"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Levy F, Laurent M, Monin JL, Maillet JM, Pasquet A, Le Tourneau T, et al. Aortic valve replacement for low-flow\/low-gradient aortic stenosis operative risk stratification and long-term outcome: A European multicenter study. <i>J Am Coll Cardiol<\/i> 2008; 51: 1466\u20131472.","DOI":"10.1016\/j.jacc.2007.10.067"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ribeiro HB, Lerakis S, Gilard M, Cavalcante JL, Makkar R, Herrmann HC, et al. Transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis: The TOPAS-TAVI registry. <i>J Am Coll Cardiol<\/i> 2018; 71: 1297\u20131308.","DOI":"10.1016\/j.jacc.2018.01.054"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Bagur R, Pibarot P, Otto CM. Importance of the valve durability-life expectancy ratio in selection of a prosthetic aortic valve. <i>Heart<\/i> 2017; 103: 1756\u20131759.","DOI":"10.1136\/heartjnl-2017-312348"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Martin C, Sun W. Comparison of transcatheter aortic valve and surgical bioprosthetic valve durability: A fatigue simulation study. <i>J Biomech<\/i> 2015; 48: 3026\u20133034.","DOI":"10.1016\/j.jbiomech.2015.07.031"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Douglas PS, Leon MB, Mack MJ, Svensson LG, Webb JG, Hahn RT, et al. Longitudinal hemodynamics of transcatheter and surgical aortic valves in the PARTNER trial. <i>JAMA Cardiol<\/i> 2017; 2: 1197\u20131206.","DOI":"10.1001\/jamacardio.2017.3306"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Barbanti M, Petronio AS, Ettori F, Latib A, Bedogni F, De Marco F, et al. 5-Year outcomes after transcatheter aortic valve implantation with corevalve prosthesis. <i>JACC Cardiovasc Interv<\/i> 2015; 8: 1084\u20131091.","DOI":"10.1016\/j.jcin.2015.03.024"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Barbanti M, Costa G, Zappulla P, Todaro D, Picci A, Rapisarda G, et al. Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement. <i>J Am Heart Assoc<\/i> 2018; 7: e008440.","DOI":"10.1161\/JAHA.117.008440"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. <i>N Engl J Med<\/i> 2015; 373: 2015\u20132024.","DOI":"10.1056\/NEJMoa1509233"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Chakravarty T, Sondergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: An observational study. <i>Lancet<\/i> 2017; 389: 2383\u20132392.","DOI":"10.1016\/S0140-6736(17)30757-2"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Frank D, Abdel-Wahab M, Gilard M, Digne F, Souteyrand G, Caussin C, et al. Characteristics and outcomes of patients \u226475 years who underwent transcatheter aortic valve implantation: Insights from the SOURCE 3 Registry. <i>Clin Res Cardiol<\/i>, doi:10.1007\/s00392-018-1404-2.","DOI":"10.1007\/s00392-018-1404-2"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Eggebrecht H, Bestehorn K, Rassaf T, Bestehorn M, Voigtlander T, Fleck E, et al. In-hospital outcomes after transcatheter or surgical aortic valve replacement in younger patients less than 75 years old: A propensity-matched comparison. <i>EuroIntervention<\/i> 2018; 14: 50\u201357.","DOI":"10.4244\/EIJ-D-17-01051"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. <i>JAMA<\/i> 2014; 312: 162\u2013170.","DOI":"10.1001\/jama.2014.7246"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Webb JG, Mack MJ, White JM, Dvir D, Blanke P, Herrmann HC, et al. Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 Valve-in-Valve registry. <i>J Am Coll Cardiol<\/i> 2017; 69: 2253\u20132262.","DOI":"10.1016\/j.jacc.2017.02.057"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Gozdek M, Raffa GM, Suwalski P, Kolodziejczak M, Anisimowicz L, Kubica J, et al. Comparative performance of transcatheter aortic valve-in-valve implantation versus conventional surgical redo aortic valve replacement in patients with degenerated aortic valve bioprostheses: Systematic review and meta-analysis. <i>Eur J Cardiothorac Surg<\/i> 2018; 53: 495\u2013504.","DOI":"10.1093\/ejcts\/ezx347"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Tuzcu EM, Kapadia SR, Vemulapalli S, Carroll JD, Holmes DR Jr, Mack MJ, et al. Transcatheter aortic valve replacement of failed surgically implanted bioprostheses: The STS\/ACC registry. <i>J Am Coll Cardiol<\/i> 2018; 72: 370\u2013382.","DOI":"10.1016\/j.jacc.2018.04.074"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Barbanti M, Webb JG, Tamburino C, Van Mieghem NM, Makkar RR, Piazza N, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure. <i>Circ Cardiovasc Interv<\/i> 2016; 9: e003930.","DOI":"10.1161\/CIRCINTERVENTIONS.116.003930"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Panoulas VF, Sutaria N, Sen S, Frame A, Ariff B, Gopalan D, et al. Transcatheter aortic valve implantation in the young. <i>Int J Cardiol<\/i> 2016; 203: 626\u2013628.","DOI":"10.1016\/j.ijcard.2015.10.243"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Faria R, Caeiro D, Fontes de Carvalho R, Lima F, Mota JC, Rodrigues A, et al. Transcatheter aortic valve implantation in a very young patient. <i>Rev Port Cardiol<\/i> 2013; 32: 827\u2013831.","DOI":"10.1016\/j.repc.2013.04.005"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Rodes-Cabau J, Masson JB, Welsh RC, Garcia Del Blanco B, Pelletier M, Webb JG, et al. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: The ARTE (Aspirin Versus Aspirin+Clopidogrel Following Transcatheter Aortic Valve Implantation) randomized clinical trial. <i>JACC Cardiovasc Interv<\/i> 2017; 10: 1357\u20131365.","DOI":"10.1016\/j.jcin.2017.04.014"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/5\/83_CJ-19-0096\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T03:30:03Z","timestamp":1556335803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/5\/83_CJ-19-0096\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0096","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]}}}